Publications
Columns
News
App Notes
Conferences
Webcasts
Resources
Directory
Subscribe

Spotlight -

The State of The Art in Life Science|

The Future of Mass Spectrometry|

Advances in Gas Chromatography

Rachel A. Ronci

Rachel A. Ronci is with Tanvex Biopharma USA, Inc. in San Diego, California.

Articles by Rachel A. Ronci

Human monoclonal antibody to fight cancer | Image Credit: © Yuriy - stock.adobe.com

Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC Method

ByHaley Sutton,Hong Truong,Xuemei Han,Rachel A. Ronci,Falguni Patel,Navin Rauniyar

June 28th 2024

In biotherapeutics manufacturing, controlling size variants of therapeutic monoclonal antibodies (mAbs) is critical for ensuring product quality.

Latest Updated Articles

Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC Method
Published: June 28th 2024 | Updated:

Trending on LCGC International

Translating Scientific Skills Into Impact: Careers Beyond Research and Academia

Saying Goodbye to LCGC International

Advancing Cannabinoid Profiling with UHPLC-MS Chromatography

The Essential Skills Needed for Leading a Lab

From Connections to Career Growth: A Guide for Early-Career Scientists